REGN logo

REGN Long term debt

Annual long term debt:

$2.70B+$1.50M(+0.06%)
December 31, 2024

Summary

  • As of today (June 29, 2025), REGN annual long term debt is $2.70 billion, with the most recent change of +$1.50 million (+0.06%) on December 31, 2024.
  • During the last 3 years, REGN annual long term debt has risen by +$724.40 million (+36.59%).
  • REGN annual long term debt is now at all-time high.

Performance

REGN Long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNbalance sheet metrics

Quarterly long term debt:

$2.70B+$400.00K(+0.01%)
March 31, 2025

Summary

  • As of today (June 29, 2025), REGN quarterly long term debt is $2.70 billion, with the most recent change of +$400.00 thousand (+0.01%) on March 31, 2025.
  • Over the past year, REGN quarterly long term debt has increased by +$1.50 million (+0.06%).
  • REGN quarterly long term debt is now at all-time high.

Performance

REGN Quarterly long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNbalance sheet metrics

Long term debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

REGN Long term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+0.1%+0.1%
3 y3 years+36.6%+0.2%
5 y5 years+278.8%+278.2%

REGN Long term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+36.6%at high+0.2%
5 y5-yearat high+278.8%at high+278.2%
alltimeall timeat high>+9999.0%at high>+9999.0%

REGN Long term debt History

DateAnnualQuarterly
Mar 2025
-
$2.70B(+0.0%)
Dec 2024
$2.70B(+0.1%)
$2.70B(+0.0%)
Sep 2024
-
$2.70B(+0.0%)
Jun 2024
-
$2.70B(+0.0%)
Mar 2024
-
$2.70B(+0.0%)
Dec 2023
$2.70B(+0.1%)
$2.70B(+0.0%)
Sep 2023
-
$2.70B(+0.0%)
Jun 2023
-
$2.70B(+0.0%)
Mar 2023
-
$2.70B(+0.0%)
Dec 2022
$2.70B(+36.4%)
$2.70B(+0.0%)
Sep 2022
-
$2.70B(+0.0%)
Jun 2022
-
$2.70B(+0.0%)
Mar 2022
-
$2.70B(+36.4%)
Dec 2021
$1.98B(-26.5%)
$1.98B(+0.0%)
Sep 2021
-
$1.98B(+0.0%)
Jun 2021
-
$1.98B(+0.0%)
Mar 2021
-
$1.98B(-26.6%)
Dec 2020
$2.70B(+277.6%)
$2.70B(+0.0%)
Sep 2020
-
$2.69B(+276.4%)
Jun 2020
-
$715.90M(+0.1%)
Mar 2020
-
$715.20M(+0.2%)
Dec 2019
$713.90M(+0.8%)
$713.90M(+0.2%)
Sep 2019
-
$712.70M(+0.2%)
Jun 2019
-
$711.30M(+0.2%)
Mar 2019
-
$709.90M(+0.2%)
Dec 2018
$708.50M(+0.7%)
$708.50M(+0.2%)
Sep 2018
-
$707.20M(+0.2%)
Jun 2018
-
$705.90M(+0.2%)
Mar 2018
-
$704.64M(+0.2%)
Dec 2017
$703.50M(+100.1%)
$703.50M(+0.2%)
Sep 2017
-
$702.32M(+0.2%)
Jun 2017
-
$701.17M(+0.1%)
Mar 2017
-
$700.41M(+99.2%)
Dec 2016
$351.57M(-3.1%)
$351.57M(-8.0%)
Sep 2016
-
$382.23M(+5.7%)
Jun 2016
-
$361.52M(-0.2%)
Mar 2016
-
$362.23M(-0.2%)
Dec 2015
$362.92M(-20.7%)
$362.92M(-8.1%)
Sep 2015
-
$394.87M(+1.8%)
Jun 2015
-
$388.05M(-17.9%)
Mar 2015
-
$472.48M(+3.2%)
Dec 2014
$457.71M(-9.3%)
$457.71M(-18.9%)
Sep 2014
-
$564.06M(+9.1%)
Jun 2014
-
$516.79M(-2.5%)
Mar 2014
-
$530.05M(+5.0%)
Dec 2013
$504.57M(+10.7%)
$504.57M(+4.8%)
Sep 2013
-
$481.38M(+1.9%)
Jun 2013
-
$472.51M(+2.4%)
Mar 2013
-
$461.27M(+1.2%)
Dec 2012
$455.95M(+4.9%)
$455.95M(+1.2%)
Sep 2012
-
$450.46M(+1.2%)
Jun 2012
-
$445.05M(+1.2%)
Mar 2012
-
$439.74M(+1.2%)
Dec 2011
$434.53M(+172.7%)
$434.53M(+172.5%)
Sep 2011
-
$159.48M(+0.0%)
Jun 2011
-
$159.46M(+0.1%)
Mar 2011
-
$159.35M(-0.0%)
Dec 2010
$159.35M(+46.2%)
$159.35M(+0.6%)
Sep 2010
-
$158.38M(+0.7%)
Jun 2010
-
$157.36M(+0.6%)
Mar 2010
-
$156.46M(+43.5%)
Dec 2009
$109.02M
$109.02M(+74.2%)
Sep 2009
-
$62.57M(-0.6%)
Jun 2009
-
$62.92M(-68.5%)
Sep 2007
-
$200.00M(0.0%)
DateAnnualQuarterly
Jun 2007
-
$200.00M(0.0%)
Mar 2007
-
$200.00M(0.0%)
Dec 2006
$200.00M(0.0%)
$200.00M(0.0%)
Sep 2006
-
$200.00M(0.0%)
Jun 2006
-
$200.00M(0.0%)
Mar 2006
-
$200.00M(0.0%)
Dec 2005
$200.00M(0.0%)
$200.00M(0.0%)
Sep 2005
-
$200.00M(0.0%)
Jun 2005
-
$200.00M(0.0%)
Mar 2005
-
$200.00M(0.0%)
Dec 2004
$200.00M(0.0%)
$200.00M(0.0%)
Sep 2004
-
$200.00M(0.0%)
Jun 2004
-
$200.00M(0.0%)
Mar 2004
-
$200.00M(0.0%)
Dec 2003
$200.00M(0.0%)
$200.00M(0.0%)
Sep 2003
-
$200.00M(-2.5%)
Jun 2003
-
$205.15M(+2.6%)
Mar 2003
-
$200.00M(0.0%)
Dec 2002
$200.00M(-0.1%)
$200.00M(0.0%)
Sep 2002
-
$200.00M(0.0%)
Jun 2002
-
$200.00M(-0.0%)
Mar 2002
-
$200.05M(-0.0%)
Dec 2001
$200.15M(+9573.8%)
$200.15M(>+9900.0%)
Sep 2001
-
$1.65M(-5.9%)
Jun 2001
-
$1.75M(-8.6%)
Mar 2001
-
$1.91M(-7.5%)
Dec 2000
$2.07M(-23.4%)
$2.07M(-5.0%)
Sep 2000
-
$2.18M(-6.8%)
Jun 2000
-
$2.34M(-7.3%)
Mar 2000
-
$2.52M(-6.7%)
Dec 1999
$2.70M(-12.9%)
$2.70M(+28.6%)
Sep 1999
-
$2.10M(-16.0%)
Jun 1999
-
$2.50M(-10.7%)
Mar 1999
-
$2.80M(-9.7%)
Dec 1998
$3.10M(-18.4%)
$3.10M(+14.8%)
Sep 1998
-
$2.70M(-25.0%)
Jun 1998
-
$3.60M(+2.9%)
Mar 1998
-
$3.50M(-7.9%)
Dec 1997
$3.80M(-25.5%)
$3.80M(-7.3%)
Sep 1997
-
$4.10M(-2.4%)
Jun 1997
-
$4.20M(-4.5%)
Mar 1997
-
$4.40M(-13.7%)
Dec 1996
$5.10M(-15.0%)
$5.10M(-1.9%)
Sep 1996
-
$5.20M(+6.1%)
Jun 1996
-
$4.90M(0.0%)
Mar 1996
-
$4.90M(-18.3%)
Dec 1995
$6.00M(-34.8%)
$6.00M(-14.3%)
Sep 1995
-
$7.00M(-9.1%)
Jun 1995
-
$7.70M(-10.5%)
Mar 1995
-
$8.60M(-6.5%)
Dec 1994
$9.20M(+55.9%)
$9.20M(+15.0%)
Sep 1994
-
$8.00M(+11.1%)
Jun 1994
-
$7.20M(-11.1%)
Mar 1994
-
$8.10M(+37.3%)
Dec 1993
$5.90M(+1.7%)
$5.90M(-4.8%)
Sep 1993
-
$6.20M(-1.6%)
Jun 1993
-
$6.30M(0.0%)
Mar 1993
-
$6.30M(+8.6%)
Dec 1992
$5.80M(+141.7%)
$5.80M(+11.5%)
Sep 1992
-
$5.20M(+8.3%)
Jun 1992
-
$4.80M(+17.1%)
Mar 1992
-
$4.10M(+70.8%)
Dec 1991
$2.40M
$2.40M(+242.9%)
Sep 1991
-
$700.00K(+133.3%)
Jun 1991
-
$300.00K

FAQ

  • What is Regeneron Pharmaceuticals annual long term debt?
  • What is the all time high annual long term debt for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals annual long term debt year-on-year change?
  • What is Regeneron Pharmaceuticals quarterly long term debt?
  • What is the all time high quarterly long term debt for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals quarterly long term debt year-on-year change?

What is Regeneron Pharmaceuticals annual long term debt?

The current annual long term debt of REGN is $2.70B

What is the all time high annual long term debt for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high annual long term debt is $2.70B

What is Regeneron Pharmaceuticals annual long term debt year-on-year change?

Over the past year, REGN annual long term debt has changed by +$1.50M (+0.06%)

What is Regeneron Pharmaceuticals quarterly long term debt?

The current quarterly long term debt of REGN is $2.70B

What is the all time high quarterly long term debt for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high quarterly long term debt is $2.70B

What is Regeneron Pharmaceuticals quarterly long term debt year-on-year change?

Over the past year, REGN quarterly long term debt has changed by +$1.50M (+0.06%)
On this page